JPS5557572A - Diphenylbutyllpiperazinecarboxamide and carbothioamide*its acid addition salt*its manufacture and medical composition containing it - Google Patents
Diphenylbutyllpiperazinecarboxamide and carbothioamide*its acid addition salt*its manufacture and medical composition containing itInfo
- Publication number
- JPS5557572A JPS5557572A JP13581779A JP13581779A JPS5557572A JP S5557572 A JPS5557572 A JP S5557572A JP 13581779 A JP13581779 A JP 13581779A JP 13581779 A JP13581779 A JP 13581779A JP S5557572 A JPS5557572 A JP S5557572A
- Authority
- JP
- Japan
- Prior art keywords
- acid addition
- diphenylbutyllpiperazinecarboxamide
- carbothioamide
- manufacture
- composition containing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000002253 acid Substances 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 title abstract 2
- 150000003839 salts Chemical class 0.000 title abstract 2
- 238000004519 manufacturing process Methods 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 3
- 241001465754 Metazoa Species 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/20—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
- C07D295/215—Radicals derived from nitrogen analogues of carbonic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, ***e
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/04—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
- C07D295/182—Radicals derived from carboxylic acids
- C07D295/185—Radicals derived from carboxylic acids from aliphatic carboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
- C07D295/194—Radicals derived from thio- or thiono carboxylic acids
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L1/00—Enclosures; Chambers
- B01L1/52—Transportable laboratories; Field kits
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Anesthesiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE7810971 | 1978-10-20 |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS5557572A true JPS5557572A (en) | 1980-04-28 |
JPS6326756B2 JPS6326756B2 (ja) | 1988-05-31 |
Family
ID=20336152
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP13581779A Granted JPS5557572A (en) | 1978-10-20 | 1979-10-19 | Diphenylbutyllpiperazinecarboxamide and carbothioamide*its acid addition salt*its manufacture and medical composition containing it |
Country Status (21)
Country | Link |
---|---|
US (3) | US4308387A (ja) |
JP (1) | JPS5557572A (ja) |
AT (1) | AT376666B (ja) |
AU (1) | AU529260B2 (ja) |
BE (1) | BE879528A (ja) |
CA (1) | CA1130807A (ja) |
CH (1) | CH643247A5 (ja) |
DE (1) | DE2941880A1 (ja) |
DK (1) | DK149057C (ja) |
ES (1) | ES485188A1 (ja) |
FI (1) | FI73986C (ja) |
FR (1) | FR2439187A1 (ja) |
GB (1) | GB2037745B (ja) |
HK (1) | HK57184A (ja) |
IT (1) | IT1207269B (ja) |
LU (1) | LU81807A1 (ja) |
NL (2) | NL190160C (ja) |
NO (1) | NO154582C (ja) |
NZ (1) | NZ191867A (ja) |
SE (1) | SE448730B (ja) |
SG (1) | SG7384G (ja) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1990013539A1 (en) * | 1989-04-28 | 1990-11-15 | Meiji Seika Kaisha, Ltd. | New n-substituted piperazine derivatives and drug for improving functional disorder of brain |
EP0730865A1 (en) * | 1995-01-12 | 1996-09-11 | Sumitomo Pharmaceuticals Company, Limited | Use of serotonin and dopamine receptor blockers for the treatment of mental disorders associated with cerebrovascular disease |
JP2007162858A (ja) * | 2005-12-15 | 2007-06-28 | Takara Belmont Co Ltd | ショックレス弁およびショックレス弁を接続した油圧回路 |
JP2010169206A (ja) * | 2009-01-23 | 2010-08-05 | Finesinter Co Ltd | ノンリークショックレス電磁比例制御弁 |
JP4776844B2 (ja) * | 1999-10-07 | 2011-09-21 | グラクソ グループ リミテッド | 化合物 |
Families Citing this family (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE791501A (fr) * | 1971-11-19 | 1973-05-17 | Albert Ag Chem Werke | Diamines cycliques n,n'-disubstituees et leur procede de preparation |
US4492698A (en) * | 1980-06-16 | 1985-01-08 | Bjoerk Anders K | Diphenylbutyl-1-acylpiperazines |
US4624953A (en) * | 1981-12-02 | 1986-11-25 | Bjoerk Anders K | 1-piperazinocarboxylates and pharmaceutical compositions containing them |
US4543352A (en) * | 1983-04-29 | 1985-09-24 | William H. Rorer, Inc. | Naphthalene aminoalkylene ethers and thioethers, and their pharmaceutical uses |
AT387572B (de) * | 1983-05-20 | 1989-02-10 | Ferrosan Ab | Verfahren zur herstellung von neuen 4-(4,4-bis-(p-fluorphenyl)-butyl)-1-carbophenox -piperazinen und von 1-piperazincarboxamiden |
ES524680A0 (es) | 1983-08-02 | 1984-12-16 | Espanola Farma Therapeut | Procedimiento de obtencion de nuevos compuestos derivados de la difenil-metilen-etilamina. |
SE8304361D0 (sv) * | 1983-08-10 | 1983-08-10 | Ferrosan Ab | Novel 1-acylpiperazine derivatives novel 1-acylpiperazine derivatives |
FR2558162B1 (fr) * | 1984-01-17 | 1986-04-25 | Adir | Nouveaux derives de la xanthine, leurs procedes de preparation et les compositions pharmaceutiques les renfermant |
SE8500573D0 (sv) * | 1985-02-08 | 1985-02-08 | Ferrosan Ab | Novel piperazinecarboxamides having a phenoxyalkyl or thiophenoxyalkyl side chain |
US4960776A (en) * | 1987-01-28 | 1990-10-02 | A. H. Robins Company, Inc. | 4-aryl-N-(alkylaminoalkyl, heterocyclicamino and heterocyclicamino)alkyl)-1-piperazinecarboxamides |
FR2673182A1 (fr) * | 1991-02-22 | 1992-08-28 | Univ Caen | Piperazines n,n'-disubstituees, leur procede de preparation et leur application en therapeutique. |
SE9100860D0 (sv) * | 1991-03-22 | 1991-03-22 | Kabi Pharmacia Ab | New use |
SE9201239D0 (sv) * | 1992-04-21 | 1992-04-21 | Kabi Pharmacia Ab | Agents for treating substance abuse disorders |
DE4219973A1 (de) * | 1992-06-19 | 1993-12-23 | Basf Ag | N-substituierte Azabicycloheptan-Derivate, ihre Herstellung und Verwendung |
SE9202266D0 (sv) * | 1992-07-31 | 1992-07-31 | Kabi Pharmacia Ab | Novel piperazine carboxamides |
DE4307181C1 (de) * | 1993-03-08 | 1994-11-10 | Dresden Arzneimittel | Verfahren zur Herstellung von 5H-Dibenz/b,f/azepin-5-carboxamid |
DE4341403A1 (de) * | 1993-12-04 | 1995-06-08 | Basf Ag | N-substituierte 3-Azabicycloalkan-Derivate, ihre Herstellung und Verwendung |
DE29815747U1 (de) | 1998-09-02 | 2000-01-05 | Ramsauer, Dieter, 42555 Velbert | Anschraubscharnier mit Raststellung |
USRE39921E1 (en) | 1999-10-07 | 2007-11-13 | Smithkline Beecham Corporation | Chemical compounds |
GB0025354D0 (en) * | 2000-10-17 | 2000-11-29 | Glaxo Group Ltd | Chemical compounds |
GB0108594D0 (en) * | 2001-04-05 | 2001-05-23 | Glaxo Group Ltd | Chemical compounds |
US7332182B2 (en) | 2001-08-06 | 2008-02-19 | Purdue Pharma L.P. | Pharmaceutical formulation containing opioid agonist, opioid antagonist and irritant |
US7842307B2 (en) | 2001-08-06 | 2010-11-30 | Purdue Pharma L.P. | Pharmaceutical formulation containing opioid agonist, opioid antagonist and gelling agent |
US20030044458A1 (en) * | 2001-08-06 | 2003-03-06 | Curtis Wright | Oral dosage form comprising a therapeutic agent and an adverse-effect agent |
US7157103B2 (en) | 2001-08-06 | 2007-01-02 | Euro-Celtique S.A. | Pharmaceutical formulation containing irritant |
US20030068375A1 (en) | 2001-08-06 | 2003-04-10 | Curtis Wright | Pharmaceutical formulation containing gelling agent |
US7141250B2 (en) * | 2001-08-06 | 2006-11-28 | Euro-Celtique S.A. | Pharmaceutical formulation containing bittering agent |
US7482365B2 (en) * | 2002-02-08 | 2009-01-27 | Glaxo Group Limited | Piperidylcarboxamide derivatives and their use in the treatment of tachykinin-mediated diseases |
GB0203022D0 (en) * | 2002-02-08 | 2002-03-27 | Glaxo Group Ltd | Chemical compounds |
GB0203020D0 (en) | 2002-02-08 | 2002-03-27 | Glaxo Group Ltd | Chemical compounds |
HUE037643T2 (hu) | 2004-06-12 | 2018-09-28 | Collegium Pharmaceutical Inc | Visszaélésre nem alkalmas gyógyszerkészítmények |
US10668060B2 (en) | 2009-12-10 | 2020-06-02 | Collegium Pharmaceutical, Inc. | Tamper-resistant pharmaceutical compositions of opioids and other drugs |
DK2826467T3 (en) | 2010-12-22 | 2017-10-16 | Purdue Pharma Lp | INCLUDED, MANIPULATION-PROPOSED SLOW-DELIVERY DOSAGE FORMS |
CN107412173A (zh) | 2010-12-23 | 2017-12-01 | 普渡制药公司 | 抗篡改固体口服剂型 |
AU2014215478B2 (en) | 2013-02-05 | 2018-09-13 | Purdue Pharma L.P. | Tamper resistant pharmaceutical formulations |
US10751287B2 (en) | 2013-03-15 | 2020-08-25 | Purdue Pharma L.P. | Tamper resistant pharmaceutical formulations |
US9737530B1 (en) | 2016-06-23 | 2017-08-22 | Collegium Pharmaceutical, Inc. | Process of making stable abuse-deterrent oral formulations |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS518283A (en) * | 1974-07-09 | 1976-01-23 | Kyorin Seiyaku Kk | 11 * 33 fuenirupuropiru * 44 karubamoirupiperajinjudotaino seizoho |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL137318C (ja) * | 1964-06-09 | |||
JPS5346988A (en) * | 1976-10-07 | 1978-04-27 | Kyorin Seiyaku Kk | Piperadine derivative |
-
1979
- 1979-10-15 NO NO793315A patent/NO154582C/no unknown
- 1979-10-16 DE DE19792941880 patent/DE2941880A1/de active Granted
- 1979-10-18 FR FR7925953A patent/FR2439187A1/fr active Granted
- 1979-10-18 CH CH938379A patent/CH643247A5/de not_active IP Right Cessation
- 1979-10-18 IT IT7926603A patent/IT1207269B/it active Protection Beyond IP Right Term
- 1979-10-18 US US06/086,068 patent/US4308387A/en not_active Expired - Lifetime
- 1979-10-18 FI FI793238A patent/FI73986C/fi not_active IP Right Cessation
- 1979-10-19 DK DK442779A patent/DK149057C/da not_active IP Right Cessation
- 1979-10-19 JP JP13581779A patent/JPS5557572A/ja active Granted
- 1979-10-19 SE SE7908701A patent/SE448730B/sv not_active IP Right Cessation
- 1979-10-19 GB GB7936297A patent/GB2037745B/en not_active Expired
- 1979-10-19 NZ NZ191867A patent/NZ191867A/xx unknown
- 1979-10-19 CA CA338,084A patent/CA1130807A/en not_active Expired
- 1979-10-19 NL NLAANVRAGE7907741,A patent/NL190160C/xx not_active IP Right Cessation
- 1979-10-19 BE BE0/197737A patent/BE879528A/fr not_active IP Right Cessation
- 1979-10-19 AU AU51984/79A patent/AU529260B2/en not_active Expired
- 1979-10-19 LU LU81807A patent/LU81807A1/de unknown
- 1979-10-19 ES ES485188A patent/ES485188A1/es not_active Expired
- 1979-10-19 AT AT0683479A patent/AT376666B/de not_active IP Right Cessation
-
1981
- 1981-01-23 US US06/227,690 patent/US4385057A/en not_active Expired - Lifetime
-
1982
- 1982-09-15 US US06/418,685 patent/US4447433A/en not_active Expired - Lifetime
-
1984
- 1984-01-26 SG SG73/84A patent/SG7384G/en unknown
- 1984-07-26 HK HK571/84A patent/HK57184A/xx not_active IP Right Cessation
-
1994
- 1994-03-23 NL NL940004C patent/NL940004I1/nl unknown
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS518283A (en) * | 1974-07-09 | 1976-01-23 | Kyorin Seiyaku Kk | 11 * 33 fuenirupuropiru * 44 karubamoirupiperajinjudotaino seizoho |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1990013539A1 (en) * | 1989-04-28 | 1990-11-15 | Meiji Seika Kaisha, Ltd. | New n-substituted piperazine derivatives and drug for improving functional disorder of brain |
EP0730865A1 (en) * | 1995-01-12 | 1996-09-11 | Sumitomo Pharmaceuticals Company, Limited | Use of serotonin and dopamine receptor blockers for the treatment of mental disorders associated with cerebrovascular disease |
JP4776844B2 (ja) * | 1999-10-07 | 2011-09-21 | グラクソ グループ リミテッド | 化合物 |
JP2007162858A (ja) * | 2005-12-15 | 2007-06-28 | Takara Belmont Co Ltd | ショックレス弁およびショックレス弁を接続した油圧回路 |
JP2010169206A (ja) * | 2009-01-23 | 2010-08-05 | Finesinter Co Ltd | ノンリークショックレス電磁比例制御弁 |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPS5557572A (en) | Diphenylbutyllpiperazinecarboxamide and carbothioamide*its acid addition salt*its manufacture and medical composition containing it | |
SE7614258L (sv) | Forfarande for framstellning av kinazoloderivat | |
GR77915B (ja) | ||
DE2964903D1 (en) | 2-lower alkyl-7-substituted-2 or 3-cephem-4-carboxylic acid compounds, processes for their preparation and pharmaceutical compositions containing them | |
SE8005712L (sv) | Polyprenylkarboxylsyraamider, forfarande for deras framstellning samt farmaceutiska kompositioner innehallande dessa foreningar | |
NZ217418A (en) | Tricyclic heterocyclic compounds and pharmaceutical compositions | |
ES455691A1 (es) | Procedimiento para la produccion de derivados de piperacina. | |
SE7411243L (ja) | ||
SE7609495L (sv) | N-tetrahydrofurfuryl-noroximorfon, dess syraadditionssalter, lekemedel innehallande dessa samt forfarande for framstellning derav | |
FI845019A0 (fi) | Farmaceutiskt preparat foer behandling av reumatiska sjukdomar. | |
ZA826453B (en) | Tricyclic thiazolyloxamic acids and their derivatives,their preparation,and therapeutic agents containing these compounds | |
DE3371515D1 (en) | Cycloalkyl derivatives of benzisoselenazolones, process for their preparation and pharmaceutical compositions containing them | |
JPS5545681A (en) | 88chloroo66hydroxyy55methylbenzoic acid derivative | |
ES8307778A1 (es) | Procedimiento para preparar difenilbutil-1-piperazinocarboxilatos. | |
IL71068A0 (en) | N-arylpiperazine derivative,its preparation and pharmaceutical compositions containing it | |
IL61769A0 (en) | 2-phenylamino-imidazolines-(2),their preparation and pharmaceutical compositions containing them | |
JPS57142961A (en) | Basic substituted anthranilic acid | |
SE7907251L (sv) | Nya metyl-l-piperidinol-4-estrar och sett att framstella dessa samt farmaceutiska kompositioner, innehallande nemnda estrar | |
SE7907656L (sv) | 3,4-dihydroxikanelaldehydderivat | |
ATE225T1 (de) | Neue substituierte 2-phenylamino-imidazoline-(2), deren saeureadditionssalze, diese enthaltende arzneimittel und verfahren zur herstellung derselben. | |
ES8302721A1 (es) | Un procedimiento para la preparacion de derivados de cefa- losporina |